newsfilter
← Latest News
GlobeNewswire·

Allakos Announces a Restructuring to Focus on Development of AK006

Existing cash to fund planned ongoing operations into mid-2026AK006 is being tested in a comprehensive Phase 1 clinical program, including: ongoing single and multiple ascending dose trial in healthy volunteersa